Oseltamivir Phosphate for Oral Suspension 6mg/ml — Class II drug recall D-0327-2024
Terminated recall by Amneal Pharmaceuticals of New York, LLC, reported 2024-02-28, distributed nationwide. Failed Impurities/Degradation Specifications: Out-of-specification test results.
| Recall number | D-0327-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Amneal Pharmaceuticals of New York, LLC, Brookhaven, NY, United States |
| Recall initiated | 2024-02-13 |
| Classified | 2024-02-16 |
| Reported by FDA | 2024-02-28 |
| Terminated | 2025-02-14 |
| Distributed | Nationwide (US) |
| Quantity | 46,037 bottles |
| Reason classes | specification failure |
| NDC | 69238-1273, 69238-1273-06 |
| Lot numbers | BF22722A, BJ15122A |
| Expiration dates | 2024-08-31, 2024-09-30 |
Product
Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC# 69238-1273-6
Reason for recall
Failed Impurities/Degradation Specifications: Out-of-specification test results.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0327-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.